GB9907822D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB9907822D0
GB9907822D0 GBGB9907822.2A GB9907822A GB9907822D0 GB 9907822 D0 GB9907822 D0 GB 9907822D0 GB 9907822 A GB9907822 A GB 9907822A GB 9907822 D0 GB9907822 D0 GB 9907822D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9907822.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB9907822.2A priority Critical patent/GB9907822D0/en
Publication of GB9907822D0 publication Critical patent/GB9907822D0/en
Priority to EP99950595A priority patent/EP1121104B1/en
Priority to PL348734A priority patent/PL196945B1/en
Priority to AT99950595T priority patent/ATE286725T1/en
Priority to CN99811633A priority patent/CN1406126A/en
Priority to PT99950595T priority patent/PT1121104E/en
Priority to CA002342340A priority patent/CA2342340C/en
Priority to ES99950595T priority patent/ES2237163T3/en
Priority to PCT/EP1999/007298 priority patent/WO2000019985A2/en
Priority to RU2001111884/15A priority patent/RU2286766C2/en
Priority to HU0103883A priority patent/HUP0103883A3/en
Priority to KR1020017003384A priority patent/KR100603900B1/en
Priority to BR9914251-1A priority patent/BR9914251A/en
Priority to TR2001/00931T priority patent/TR200100931T2/en
Priority to AU63321/99A priority patent/AU764866B2/en
Priority to NZ510683A priority patent/NZ510683A/en
Priority to IDW20010671A priority patent/ID27504A/en
Priority to SK439-2001A priority patent/SK285250B6/en
Priority to CZ20011155A priority patent/CZ302888B6/en
Priority to DE69923200T priority patent/DE69923200T2/en
Priority to IL14176299A priority patent/IL141762A0/en
Priority to JP2000573347A priority patent/JP4012689B2/en
Priority to IL141762A priority patent/IL141762A/en
Priority to ZA2001/01932A priority patent/ZA200101932B/en
Priority to NO20011471A priority patent/NO331689B1/en
Priority to US09/818,690 priority patent/US20010033866A1/en
Priority to US10/118,183 priority patent/US6565883B2/en
Priority to US10/403,146 priority patent/US20030203025A1/en
Priority to HK03104925.9A priority patent/HK1052473A1/en
Priority to US11/105,967 priority patent/US20050175706A1/en
Priority to US11/592,853 priority patent/US20070053982A1/en
Ceased legal-status Critical Current

Links

GBGB9907822.2A 1998-10-01 1999-04-06 Organic compounds Ceased GB9907822D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GBGB9907822.2A GB9907822D0 (en) 1999-04-06 1999-04-06 Organic compounds
BR9914251-1A BR9914251A (en) 1998-10-01 1999-10-01 Oral sustained release formulations
AU63321/99A AU764866B2 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
SK439-2001A SK285250B6 (en) 1998-10-01 1999-10-01 Oral pharmaceutical composition comprising rivastigmine and use of rivastigmine
NZ510683A NZ510683A (en) 1998-10-01 1999-10-01 Sustained release oral formulations of rivastigmine
CN99811633A CN1406126A (en) 1998-10-01 1999-10-01 New sustained release oral formulations
PT99950595T PT1121104E (en) 1998-10-01 1999-10-01 NEW ORAL FORMULATIONS OF CONTROLLED LIBERATION
CA002342340A CA2342340C (en) 1998-10-01 1999-10-01 New sustained release oral formulations
ES99950595T ES2237163T3 (en) 1998-10-01 1999-10-01 NEW ORAL FORMULATIONS OF REVASTIGMINE CONTROLLED LIBERATION.
PCT/EP1999/007298 WO2000019985A2 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
RU2001111884/15A RU2286766C2 (en) 1999-04-06 1999-10-01 New prolonged compositions for peroral administration
HU0103883A HUP0103883A3 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
KR1020017003384A KR100603900B1 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
PL348734A PL196945B1 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
TR2001/00931T TR200100931T2 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
EP99950595A EP1121104B1 (en) 1998-10-01 1999-10-01 New controlled release oral formulations for rivastigmine
AT99950595T ATE286725T1 (en) 1998-10-01 1999-10-01 NEW ORAL MEDICINAL PREPARATIONS FOR RIVASTIGMINE WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
IDW20010671A ID27504A (en) 1998-10-01 1999-10-01 NEW ORAL FORMULATION
JP2000573347A JP4012689B2 (en) 1998-10-01 1999-10-01 New sustained-release oral preparation
CZ20011155A CZ302888B6 (en) 1998-10-01 1999-10-01 Pharmaceutical composition for oral administration comprising rivastigmine and use of rivastigmine
DE69923200T DE69923200T2 (en) 1998-10-01 1999-10-01 NEW ORAL ARRAY PREPARATIONS FOR RIVASTIGGINS WITH CONTROLLED ACTIVE INGREDIENTS
IL14176299A IL141762A0 (en) 1998-10-01 1999-10-01 New oral formulations
IL141762A IL141762A (en) 1998-10-01 2001-03-01 Controlled release oral formulations for rivastigmine
ZA2001/01932A ZA200101932B (en) 1998-10-01 2001-03-08 New sustained release oral formulations
NO20011471A NO331689B1 (en) 1998-10-01 2001-03-22 ORAL PHARMACEUTICAL COMPOSITION INCLUDING RIVASTIGMIN AND USING RIVASTIGMIN
US09/818,690 US20010033866A1 (en) 1998-10-01 2001-03-27 Sustained release oral formulations
US10/118,183 US6565883B2 (en) 1998-10-01 2002-04-08 Controlled release oral compositions comprising rivastigmine
US10/403,146 US20030203025A1 (en) 1998-10-01 2003-03-31 Sustained release oral formulations
HK03104925.9A HK1052473A1 (en) 1998-10-01 2003-07-09 New sustained release oral formulations
US11/105,967 US20050175706A1 (en) 1998-10-01 2005-04-14 Sustained release oral formulations
US11/592,853 US20070053982A1 (en) 1998-10-01 2006-11-03 Sustained release oral formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9907822.2A GB9907822D0 (en) 1999-04-06 1999-04-06 Organic compounds

Publications (1)

Publication Number Publication Date
GB9907822D0 true GB9907822D0 (en) 1999-06-02

Family

ID=10851013

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9907822.2A Ceased GB9907822D0 (en) 1998-10-01 1999-04-06 Organic compounds

Country Status (1)

Country Link
GB (1) GB9907822D0 (en)

Similar Documents

Publication Publication Date Title
GB9903759D0 (en) Organic compounds
GB9903547D0 (en) Organic compounds
GB9907097D0 (en) Organic compounds
GB9908533D0 (en) Organic compounds
GB9903548D0 (en) Organic compounds
GB9902938D0 (en) Organic compounds
GB9907908D0 (en) Organic compounds
GB9910119D0 (en) Organic compounds
GB9910965D0 (en) Organic compounds
GB9905944D0 (en) Organic compounds
GB9903878D0 (en) Organic compounds
GB9910243D0 (en) Organic compounds
GB9910320D0 (en) Organic compounds
GB9909333D0 (en) Organic compounds
GB9910832D0 (en) Organic compounds
GB9908532D0 (en) Organic compounds
GB9907822D0 (en) Organic compounds
GB9910835D0 (en) Organic compounds
GB9907823D0 (en) Organic compounds
GB9911059D0 (en) Organic compounds
GB9907094D0 (en) Organic compounds
GB9906060D0 (en) Organic compounds
GB9905946D0 (en) Organic compounds
GB9905945D0 (en) Organic compounds
GB9908468D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)